These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21884762)

  • 1. Glutamate and nicotinic receptor interactions in working memory: importance for the cognitive impairment of schizophrenia.
    Timofeeva OA; Levin ED
    Neuroscience; 2011 Nov; 195():21-36. PubMed ID: 21884762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance deficit of alpha7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory.
    Fernandes C; Hoyle E; Dempster E; Schalkwyk LC; Collier DA
    Genes Brain Behav; 2006 Aug; 5(6):433-40. PubMed ID: 16923147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia.
    Lin H; Hsu FC; Baumann BH; Coulter DA; Anderson SA; Lynch DR
    Mol Cell Neurosci; 2014 Jul; 61():163-75. PubMed ID: 24983521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic receptor subtypes and cognitive function.
    Levin ED
    J Neurobiol; 2002 Dec; 53(4):633-40. PubMed ID: 12436426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizophrenia and the alpha7 nicotinic acetylcholine receptor.
    Martin LF; Freedman R
    Int Rev Neurobiol; 2007; 78():225-46. PubMed ID: 17349863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders.
    Roncarati R; Scali C; Comery TA; Grauer SM; Aschmi S; Bothmann H; Jow B; Kowal D; Gianfriddo M; Kelley C; Zanelli U; Ghiron C; Haydar S; Dunlop J; Terstappen GC
    J Pharmacol Exp Ther; 2009 May; 329(2):459-68. PubMed ID: 19223665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective down-regulation of α4β2 neuronal nicotinic acetylcholine receptors in the brain of uremic rats with cognitive impairment.
    Ballesta JJ; del Pozo C; Castelló-Banyuls J; Faura CC
    Exp Neurol; 2012 Jul; 236(1):28-33. PubMed ID: 22510484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cog in cognition: how the alpha 7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits.
    Leiser SC; Bowlby MR; Comery TA; Dunlop J
    Pharmacol Ther; 2009 Jun; 122(3):302-11. PubMed ID: 19351547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The concept of working memory in schizophrenia: current evidence and future perspectives].
    Wolf RC; Vasic N; Walter H
    Fortschr Neurol Psychiatr; 2006 Aug; 74(8):449-68. PubMed ID: 16586253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implication of neuronal Ca2+ -sensor protein VILIP-1 in the glutamate hypothesis of schizophrenia.
    Gierke P; Zhao C; Bernstein HG; Noack C; Anand R; Heinemann U; Braunewell KH
    Neurobiol Dis; 2008 Oct; 32(1):162-75. PubMed ID: 18691652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine induction of theta frequency oscillations in rodent hippocampus in vitro.
    Lu CB; Henderson Z
    Neuroscience; 2010 Mar; 166(1):84-93. PubMed ID: 20004706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the α7 nicotinic receptor in cognitive processing of persons with schizophrenia.
    AhnAllen CG
    Curr Opin Psychiatry; 2012 Mar; 25(2):103-8. PubMed ID: 22262029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal.
    Barik J; Wonnacott S
    Mol Pharmacol; 2006 Feb; 69(2):618-28. PubMed ID: 16269536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo.
    Timmermann DB; Grønlien JH; Kohlhaas KL; Nielsen EØ; Dam E; Jørgensen TD; Ahring PK; Peters D; Holst D; Christensen JK; Malysz J; Briggs CA; Gopalakrishnan M; Olsen GM
    J Pharmacol Exp Ther; 2007 Oct; 323(1):294-307. PubMed ID: 17625074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease.
    Wallace TL; Porter RH
    Biochem Pharmacol; 2011 Oct; 82(8):891-903. PubMed ID: 21741954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of alpha7-nicotinic acetylcholine receptors in tetanic stimulation-induced gamma oscillations in rat hippocampal slices.
    Song C; Murray TA; Kimura R; Wakui M; Ellsworth K; Javedan SP; Marxer-Miller S; Lukas RJ; Wu J
    Neuropharmacology; 2005 May; 48(6):869-80. PubMed ID: 15829257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Working memory and the psychopathology of schizophrenia].
    Walter H; Wolf RC
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S16-23. PubMed ID: 18461540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinic-antipsychotic drug interactions and cognitive function.
    Levin ED; Rezvani AH
    EXS; 2006; 98():185-205. PubMed ID: 17019889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding.
    Levin ED; Tizabi Y; Rezvani AH; Caldwell DP; Petro A; Getachew B
    Brain Res; 2005 Apr; 1041(2):132-42. PubMed ID: 15829222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathophysiology of traumatic brain injury in alpha7 nicotinic cholinergic receptor knockout mice.
    Kelso ML; Wehner JM; Collins AC; Scheff SW; Pauly JR
    Brain Res; 2006 Apr; 1083(1):204-10. PubMed ID: 16545784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.